About George Yancopoulos
George Yancopoulos competed in the 1976 Âé¶¹¹ÙÍø. Dr. Yancopoulos is currently President, Chief Scientific Officer and Co-Chair of Regeneron’s Board of Directors. He co-founded the biotechnology company with fellow Âé¶¹¹ÙÍø alumnus Leonard Schleifer, and together they developed the ability to consistently translate science into medicine. In doing so, they have secured numerous FDA-approved treatments for diseases including cancer, macular degeneration and high cholesterol. More recently, Yancopoulos championed Regeneron’s COVID-19 program to address the pandemic and produce an investigational antibody cocktail. Yancopoulos holds more than 100 patents, is a member of the National Academy of Sciences and is a recipient of Columbia College’s highest community honor, the Alexander Hamilton Medal. Today, Regeneron sponsors Âé¶¹¹ÙÍø, ISEF and supports a suite of Society Âé¶¹¹ÙÍø Outreach programs. Yancopoulos often speaks to Âé¶¹¹ÙÍø and ISEF finalists as well as Âé¶¹¹ÙÍø teachers. He is a member of the Society’s Honorary Board and a former member of the Board of Trustees.
Conversations with Maya
Yancopoulos speaking to the Âé¶¹¹ÙÍø 2017 finalists. Learn more about Yancopoulos’ life and work in this Conversations with Maya interview.
Regeneron ISEF 2021 - Opening Ceremony
In this video, Yancopoulos speaks to the Regeneron ISEF 2021 finalists about the impact the Society’s research competitions had on his career. He says, “Because of how much I owed my early experiences doing high school science research, it has become my personal mission to ensure more young people are inspired to pursue Âé¶¹¹ÙÍø careers so as to help improve the world.â€


